Sutaria Dhruvitkumar - Clinical Pharmacology, Genentech

基本信息

浏览量：26

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 46 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluation of Patient-Centric Sample Collection Technologies for Pharmacokinetic Assessment of Large and Small Molecules

Sandhya Mandlekar,Dhruvitkumar S. Sutaria, Xiaoyun Yang, Ryan Johnson,Yixuan Zou,Brian Dean,Liuxi Chen,Rucha Sane,Kathi Williams,Alison Cardenas, Mary Simon,Saloumeh Fischer

CLINICAL PHARMACOLOGY & THERAPEUTICS（2024）

引用0浏览0WOS引用

Population Pharmacokinetics and Humanized Dosage Regimens Matching the Peak, Area, Trough, and Range of Amikacin Plasma Concentrations in Immune-Competent Murine Bloodstream and Lung Infection Models

Yuanyuan Jiao, Jun Yan,Dhruvitkumar S. Sutaria,Peggy Lu,Michael Vicchiarelli,Zeferino Reyna, Juan Ruiz-Delgado,Elizabeth Burk,Eugene Moon,Nirav R. Shah,Brad Spellberg,Robert A. Bonomo,George L. Drusano,Arnold Louie,Brian M. Luna,Jurgen B. Bulitta

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2024）

引用0浏览0WOS引用

Clinical Pharmacology Considerations for the "Off-the-shelf" Allogeneic Cell Therapies

Hardik Mody,Dhruvitkumar S Sutaria,Dale Miles

Clinical pharmacology and therapeuticsno. 6 (2024): 1233-1250

引用0浏览0WOS引用

Individual Components of Polymyxin B Modeled Via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice

Yuanyuan Jiao, Jun Yan,Michael Vicchiarelli,Dhruvitkumar S. Sutaria,Peggy Lu,Zeferino Reyna,Brad Spellberg,Robert A. Bonomo,George L. Drusano,Arnold Louie,Brian M. Luna,Jurgen B. Bulitta

ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 5 (2023)

引用0浏览0WOS引用

Risk Factors of Hyperglycemia after Treatment with the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning-Based Investigation

Rashed Harun,Rucha Sane,Kenta Yoshida,Dhruvitkumar S. Sutaria,Jin Y. Jin,James Lu

JCO CLINICAL CANCER INFORMATICS (2023)

引用1浏览0WOS引用

Characterization of Exposure–response Relationships of Ipatasertib in Patients with Metastatic Castration-Resistant Prostate Cancer in the IPATential150 Study

Naoki Kotani,Justin J. Wilkins,Janet R. Wade,Steve Dang,Dhruvitkumar S. Sutaria,Kenta Yoshida,Sameer Sundrani, Hao Ding,Josep Garcia,Heather Hinton,Rucha Sane,Pascal Chanu

Cancer Chemotherapy and Pharmacology（2022）

引用2浏览0WOS引用

EVALUATION OF MORNING VERSUS EVENING DOSING OF IPATASERTIB, AN AKT INHIBITOR TO MITIGATE IPATASERTIB INDUCED GLUCOSE CHANGES

D. Sutaria,P. Agarwal,S. Jones,D. Miles, J. Rotmensch,J. Gallo, G. Rasuo, H. Hinton,R. Sane

CLINICAL PHARMACOLOGY & THERAPEUTICS（2022）

引用0浏览0引用

Mitigating Ipatasertib‐induced Glucose Increase Through Dose and Meal Timing Modifications

Dhruvitkumar S. Sutaria,Priya Agarwal,Kuan-Chieh Huang,Dale R. Miles,Jacob Rotmensch,Heather Hinton,Jorge Daniel Gallo,Grozdana Rasuo,Rucha S. Sane

Clinical and Translational Science（2022）

引用5浏览0WOS引用

Drug–Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate Cancer

Dhruvitkumar S. Sutaria,Grozdana Rasuo,Adam Harris,Ryan Johnson,Dale Miles,Jorge Daniel Gallo,Rucha Sane

Pharmaceutics（2022）

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn